from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3572/-

LFCtreatmentdescriptionclass of inhibitor

-0.140

Amikacinug/mL Amikacintranslation

0.906

Cap5-10ug/mL Capreomycintranslation

2.161

Rox10-50 ug/mL Roxithromycintranslation

0.069

SM2-5 ug/mL Streptomycintranslation

-1.118

Tet5-10 ug/mL Tetracyclinetranslation

-0.197

Rif0.2-5ug/mL Rifampicintranscription

-0.064

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.631

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.864

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.341

CPZ10-50 ug/mL Chlorpromazinerespiration

0.357

Clofazimine10-13 ug/mL Clofaziminerespiration

0.231

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.257

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.237

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.123

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.232

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.258

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.039

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.577

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.684

KCN5-20 ug/mL Potassium cyaniderespiration

0.970

NaN30.2-2 mM Sodium aziderespiration

0.200

Nigericin50 uM Nigericinrespiration

-0.148

TRC10-150 ug/mL Triclosanrespiration

-0.826

TRZ10-25 ug/mL Thioridazinerespiration

-0.489

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.203

menadione6-10 ug/mL Menadionerespiration

0.536

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.225

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.237

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.205

NRP_1Non-replicating persistence stage 1dosRassociated

-0.115

Amp0.2mg/mL AmpicillincellWall

-0.616

Cephalexin20-100 ug/mL CephalexincellWall

-0.569

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.584

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.606

EMB10-20 ug/mL EthambutolcellWall

-0.750

Eta12-40 ug/mL EthionamidecellWall

-1.230

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.782

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.418

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.207

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.336

BZA0.12 mg/mL BenzamidearomaticAmides

0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.163

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.060

H2O24 mM hydrogen peroxideDNAdamaging

-0.136

Levo10 ug/mL LevofloxacinDNAdamaging

-0.006

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.984

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.600

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.077

UVUV-irradiationDNAdamaging

0.582

ARP41-4 ug/mL Antitubercular compound ARP4?

0.445

Antimycin12.5-50 ug/mL Antimycin A?

-0.178

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.233

PA_110-50 ug/mL Antitubercular compound PA-1?

0.405

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.293

PA8240.2-2 ug/mL PA-824?

-0.343

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.914

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.551

Verapamil50 uM Verapamil?

-0.152

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.155

methoxatin10-20 ug/mL Methoxatin?